{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:32:59Z","timestamp":1761823979269},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1097\/md.0000000000009636","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T16:41:45Z","timestamp":1516812105000},"page":"e9636","source":"Crossref","is-referenced-by-count":5,"title":["Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence"],"prefix":"10.1097","volume":"97","author":[{"given":"Xinjie","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210226","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3171\/jns.2005.102.2.0246","article-title":"A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center","volume":"102","author":"Kim","year":"2005","journal-title":"J Neurosurg"},{"key":"R2-12-20210226","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0194599815606700","article-title":"Comparative analysis of head and neck and non-head and neck malignant peripheral nerve sheath tumors","volume":"154","author":"Patel","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R3-12-20210226","doi-asserted-by":"crossref","first-page":"E1152","DOI":"10.1227\/NEU.0b013e31820a1599","article-title":"Recurring intracranial malignant peripheral nerve sheath tumor: case report and systematic review of the literature","volume":"68","author":"van den Munckhof","year":"2011","journal-title":"Neurosurgery"},{"key":"R4-12-20210226","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/B:NEON.0000041891.39474.cb","article-title":"Peripheral nerve tumors: management strategies and molecular insights","volume":"69","author":"Bhattacharyya","year":"2004","journal-title":"J Neurooncol"},{"key":"R5-12-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00383263","article-title":"Primary spinal malignant schwannoma: clinical, histological and cytogenetic findings","volume":"14","author":"Valdueza","year":"1991","journal-title":"Neurosurg Rev"},{"key":"R6-12-20210226","first-page":"596","article-title":"Malignant peripheral nerve sheath tumor of the infratemporal fossa with intracranial extension","volume":"89","author":"Tamarit","year":"2010","journal-title":"Ear Nose Throat J"},{"key":"R7-12-20210226","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11864-015-0328-6","article-title":"Current treatment options for malignant peripheral nerve sheath tumors","volume":"16","author":"Bradford","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"R8-12-20210226","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11060-013-1345-6","article-title":"Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program","volume":"116","author":"Amirian","year":"2014","journal-title":"J Neurooncol"},{"key":"R9-12-20210226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/neuonc\/nos287","article-title":"Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1","volume":"15","author":"Kolberg","year":"2013","journal-title":"Neuro Oncol"},{"key":"R10-12-20210226","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.0303-6987.2005.00267.x","article-title":"Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin","volume":"32","author":"Lazar","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R11-12-20210226","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4615-4149-3_3","article-title":"Defects in the regulation of beta-catenin in colorectal cancer","volume":"470","author":"Polakis","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"R12-12-20210226","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0959-437X(02)00012-6","article-title":"You Wnt some, you lose some: oncogenes in the Wnt signaling pathway","volume":"13","author":"van Es","year":"2003","journal-title":"Curr Opin Genet Dev"},{"key":"R13-12-20210226","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jcmm.12033","article-title":"Pharmacological modulation of beta-catenin and its applications in cancer therapy","volume":"17","author":"Thakur","year":"2013","journal-title":"J Cell Mol Med"},{"key":"R14-12-20210226","doi-asserted-by":"crossref","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","article-title":"The beta-catenin destruction complex","volume":"5","author":"Stamos","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R15-12-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0959-437X(99)80003-3","article-title":"The oncogenic activation of beta-catenin","volume":"9","author":"Polakis","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"R16-12-20210226","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"key":"R17-12-20210226","doi-asserted-by":"crossref","first-page":"e1000296","DOI":"10.1371\/journal.pbio.1000296","article-title":"Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner","volume":"8","author":"Notani","year":"2010","journal-title":"PLoS Biol"},{"key":"R18-12-20210226","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/BJ20111887","article-title":"A new validated mathematical model of the Wnt signalling pathway predicts effective combinational therapy by sFRP and Dkk","volume":"444","author":"Kogan","year":"2012","journal-title":"Biochem J"},{"key":"R19-12-20210226","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1158\/1078-0432.CCR-11-2322","article-title":"Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib","volume":"18","author":"Lachenmayer","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R20-12-20210226","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1940-6207.CAPR-11-0559","article-title":"A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and beta-catenin transcriptional activity","volume":"5","author":"Whitt","year":"2012","journal-title":"Cancer Prev Res (Phila"},{"key":"R21-12-20210226","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.taap.2012.03.007","article-title":"Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging","volume":"261","author":"Yeh","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"R22-12-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.08.005","article-title":"Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28","volume":"146","author":"Le","year":"2015","journal-title":"Pharmacol Ther"},{"key":"R23-12-20210226","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1349-7006.2012.02222.x","article-title":"Dickkopf-1 inhibits epithelial\u2013mesenchymal transition of colon cancer cells and contributes to colon cancer suppression","volume":"103","author":"Qi","year":"2012","journal-title":"Cancer Sci"},{"key":"R24-12-20210226","doi-asserted-by":"crossref","first-page":"14066","DOI":"10.1074\/jbc.M602696200","article-title":"Mediator is a transducer of Wnt\/beta-catenin signaling","volume":"281","author":"Kim","year":"2006","journal-title":"J Biol Chem"},{"key":"R25-12-20210226","doi-asserted-by":"crossref","first-page":"e20715","DOI":"10.1371\/journal.pone.0020715","article-title":"Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt\/beta-catenin and PTEN","volume":"6","author":"Tanwar","year":"2011","journal-title":"PLoS One"},{"key":"R26-12-20210226","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/carcin\/bgs278","article-title":"Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma","volume":"33","author":"Zhu","year":"2012","journal-title":"Carcinogenesis"},{"key":"R27-12-20210226","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cell.2012.10.035","article-title":"MED12 controls the response to multiple cancer drugs through regulation of TGF-beta receptor signaling","volume":"151","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"R28-12-20210226","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/0008-5472.CAN-07-5089","article-title":"Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype","volume":"68","author":"Bharathy","year":"2008","journal-title":"Cancer Research"},{"key":"R29-12-20210226","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF beta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:52:38Z","timestamp":1620960758000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201801260-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009636","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}